ChromaDex Corporation, a leading player in the nutraceutical and dietary supplement industry, is headquartered in the United States. Founded in 2009, the company has established itself as a pioneer in the development and commercialisation of innovative ingredients and products that support health and wellness. ChromaDex is renowned for its flagship product, TRU Niagen®, a patented form of nicotinamide riboside that promotes cellular health and energy metabolism. This unique offering has positioned the company at the forefront of the burgeoning market for NAD+ precursors, appealing to health-conscious consumers and researchers alike. With a commitment to scientific research and quality, ChromaDex has achieved significant milestones, including partnerships with major brands and recognition for its contributions to the field of nutritional science. As it continues to expand its operational reach, ChromaDex remains dedicated to enhancing the understanding of cellular health and the role of dietary supplements in overall well-being.
How does ChromaDex's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
ChromaDex's score of 25 is lower than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.
ChromaDex, headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges from the company. This lack of data suggests that ChromaDex may not have established formal commitments to reduce its carbon footprint or may not publicly disclose such information. In the context of industry standards, companies are increasingly expected to set science-based targets and report on their emissions across Scope 1, 2, and 3 categories. However, without specific data or commitments from ChromaDex, it is unclear how the company aligns with these expectations. As the climate landscape evolves, it will be important for ChromaDex to consider establishing measurable targets and transparent reporting to enhance its sustainability profile.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
ChromaDex has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
